FDA Inspection 888068 — Neil K. Singla, M.D.
The FDA completed an inspection of Neil K. Singla, M.D. on July 10, 2014 in Pasadena, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 10, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Pasadena, CA (United States)
Additional Details
Clinical Investigator (CI)